Clinical Trial Summary

---

Phase

N/A

---

Funding Agency/Sponsor

Institutional

---

Disease

Population Sciences

---

Enrollment Eligibility

Inclusion Criteria:
1. ≥ 18 years of age;
2. Hispanic/Latino self-identification;
3. Spanish speakers (including bilinguals who express interest in a Spanish-based
psychosocial intervention);
4. Primary diagnosis of localized Prostate Cancer (T1-T3, N0, M0);
5. Surgical or radiation treatment (e.g., external beam, brachytherapy, proton) within
minimum of 4 months and maximum of 72-months;
6. Some patients with prior inpatient psychiatric treatment for severe mental illness or
overt signs of severe psychopathology (e.g., psychosis) may be enrolled, per P.I.
discretion, based on a case-by-case review;
7. Willingness to be randomized and followed for approximately12 months.
Exclusion Criteria:
1. History of non-skin cancer within the last 2 years.
2. Prior inpatient psychiatric treatment for severe mental illness or overt signs of
severe psychopathology (e.g., psychosis) within the past six months, as these
conditions can interfere with adequate participation in our experimental conditions
may be exclusionary, per P.I. discretion, based on a case-by-case review;
3. Active alcohol dependence within the past six months may be exclusionary, per P.I.
discretion, based on a case-by-case review;
4. Active substance dependence within the past six months may be exclusionary, per P.I.
discretion, based on a case-by-case review; and
5. Acute or chronic immune system medical conditions, medications or conditions that
impact immune and endocrine function (e.g., Chronic Fatigue Syndrome (CFS), Lupus,
rheumatoid arthritis, Hepatitis C, or immunosuppressive treatment requiring
conditions), per PI discretion based on a case by case review.
6. Individuals scoring >3 on the SPMSQ will be excluded or per PI discretion based on a
case by case review.
.

---